SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Drug: Anti-EGFR monoclonal antibody Sponsor: Shi Yuankai Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials